Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Daniel Hoth"'
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 5, Iss Suppl A, Pp 36A-41A (1994)
The goal of a prophylactic human immunodeficiency (HIV) vaccine is to elicit immune response(s) that will, upon subsequent exposure to HIV. prevent lnfection and/or disease. On the other hand. therapeutic administration of a vaccine to an individual
Externí odkaz:
https://doaj.org/article/20dcb6834019413da8c4b6ef1195a3e8
Publikováno v:
IEEE Transactions on Quantum Engineering, Vol 5, Pp 1-26 (2024)
Accurately predicting a quantum computer's capability—which circuits it can run and how well it can run them—is a foundational goal of quantum characterization and benchmarking. As modern quantum computers become increasingly hard to simulate, we
Externí odkaz:
https://doaj.org/article/d5716fd9f2a246adaac7c29454ade838
Publikováno v:
PRX Quantum, Vol 5, Iss 3, p 030334 (2024)
We introduce binary randomized benchmarking (BiRB), a protocol that streamlines traditional RB by using circuits consisting almost entirely of independent identically distributed (IID) layers of gates. BiRB reliably and efficiently extracts the avera
Externí odkaz:
https://doaj.org/article/c2d110248f0041b2a746c700f8587d82
Autor:
Stephen W. Lagakos, Daniel Hoth
Publikováno v:
Annals of internal medicine. 116(7)
Excerpt During the last several years, extensive research has been done on surrogate markers in patients with the acquired immunodeficiency syndrome (AIDS) (1). However, many questions remain about...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::595a4e0144b6b6acc47cf56f0c02d46a
https://pubmed.ncbi.nlm.nih.gov/1355955
https://pubmed.ncbi.nlm.nih.gov/1355955
Autor:
Suzanne Trudel, Sundar Jagannath, Robert Frumento, Dixil Francis, Joseph R. Garlich, Engin Gul, Sherif S. Farag, Daniel Hoth, R. Donald Harvey, Sagar Lonial
Publikováno v:
Blood. 114:3879-3879
Abstract 3879 Poster Board III-815 Introduction Preclinical and clinical studies have demonstrated the central importance of the PI3K/AKT axis in malignant cell survival and proliferation, yet few therapeutic options have been available. SF1126 is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::deb10baa039ad482d2825c664be3ec95
https://doi.org/10.1182/blood.v114.22.3879.3879
https://doi.org/10.1182/blood.v114.22.3879.3879
Autor:
Charles K. Grieshaber, Peter J. O'Dwyer, Susan A. King, Brian Leyland-Jones, Daniel Hoth, Jacqueline Plowman
Publikováno v:
Investigational New Drugs. 6:305-310
Pyrazole (NSC-45410) is a low molecular weight, heterocyclic compound which has been considered for reevaluation in the clinic as a potential cytotoxic agent (Fig. 1). Discovered in 1893 [1], pyrazole is best known as an inhibitor of liver alcohol de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42cd5f621915eed9d55b33cdab5a4f74
https://doi.org/10.1007/bf00173649
https://doi.org/10.1007/bf00173649
Autor:
Paul V. Woolley, Philip S. Schein, Tariyln Smythe, John S. Macdonald, Winston Ueno, Daniel Hoth
Publikováno v:
Cancer. 44:42-47
Thirty-six patients with advanced measurable gastric cancer were treated with a new combination chemotherapy program consisting of 5-fluorouracil, Adriamycin and mitomycin-C (FAM). Fifty percent of patients achieved an objective partial response. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dd1e858d9e9f854c3bff690bfb72f5c
https://doi.org/10.1002/1097-0142(197907)44:1<42::aid-cncr2820440108>3.0.co
https://doi.org/10.1002/1097-0142(197907)44:1<42::aid-cncr2820440108>3.0.co
Autor:
Paul V. Woolley, Patrick J. Maguire, Branimir I. Sikic, Charles L. Litterst, John J. Gullo, Daniel Hoth
Publikováno v:
Cancer Chemotherapy and Pharmacology. 5:21-26
The pharmacokinetics of cis-dichlorodiam-minoplatinum (II) (cisplatin) have been studied in seven patients, of whom four received the drug as a one hour infusion and three received it as a 20 h infusion. The patients receiving the drug over one hour
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dcc2383e33b407a03adddb7f04f116f
https://doi.org/10.1007/bf00578558
https://doi.org/10.1007/bf00578558
Publikováno v:
Cancer Treatment Reviews. 12:43-49
Carboplatin has been developed for clinical trials as a less nephrotoxic, less emetogenic analog of cisplatin. In preclinical tumor models it was less potent than the parent compound on a molar basis, but reduced toxicity allowed comparable antitumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c41066ffc9b448c4c421703f74fce0f4
https://doi.org/10.1016/0305-7372(85)90017-9
https://doi.org/10.1016/0305-7372(85)90017-9
Publikováno v:
Journal of Clinical Oncology. 4:1563-1568
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a9a9ad4e3775b1c92858ca7ca28252a
https://doi.org/10.1200/jco.1986.4.10.1563
https://doi.org/10.1200/jco.1986.4.10.1563